Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt
Review

Remimazolam vs midazolam for sedation in upper gastrointestinal endoscopy: a systematic review and meta-analysis.

Salma Bahnasy A. O. Saleh Ibrahim A. Ababneh Bishoy Fahim T. Tarboush Rovan Aladham Ismail Elkhattib H. Eltaly Mohamed Elnaggar
Aug 2026 · Naunyn-Schmiedeberg's Archives of Pharmacology · 0 citations · 17 references
Medicine

TL;DR

In conclusion, remimazolam may represent a safe and effective alternative to midazolam for upper gastrointestinal endoscopy, with faster cognitive recovery, as reflected by shorter time to full alertness and earlier discharge.

DOI PubMed Semantic Scholar
View source

Similar papers

Review Sep 2026

Remimazolam versus sevoflurane for general anaesthesia: A meta-analysis with trial sequential analysis of haemodynamic and clinical outcomes.

BACKGROUND Remimazolam is a novel ultra-short-acting intravenous benzodiazepine, while sevoflurane is a widely used inhalational anaesthetic for general anaesthesia (GA). Both agents are associated with risks of haemodynamic instability and postoperative nausea and vomiting (PONV), which can affect patient safety and r...

L. Takayama, Kevlin de Souza, David Abraham Batista da Hora et al. · 0 citations
Review Open access Sep 2026

Ciprofol versus propofol for painless gastrointestinal endoscopy: a dose-stratified systematic review and meta-analysis

We compared ciprofol with propofol for painless gastrointestinal endoscopy, focusing on dose, recovery, induction, satisfaction, and adverse events. PubMed and Embase were searched through May 2026 for randomized controlled trials in adults undergoing painless gastrointestinal endoscopy. We pooled weighted m...

Jing Liu, Jun Yu, Zhi-Yong Chen et al. · 0 citations
Aug 2026

Comparative study on the efficacy and safety of remimazolam versus midazolam for sedation during ERCP-related procedures in the elderly.

Remimazolam significantly shortened recovery time and reduced flumazenil use in elderly patients, which may reduce staff workload after ERCP; larger studies are needed to establish comparative safety.

Suguru Ito, Y. Tanisaka, S. Ryozawa et al. · 0 citations
Review Open access Aug 2026

Intranasal dexmedetomidine versus midazolam for procedural sedation in children: a systematic review and metaanalysis of randomized controlled trials

Primary efficacy outcomes demonstrated statistically insignificant differences, although robust evidence indicates intranasal dexmedetomidine is highly superior for pediatric behavioral recovery, although robust evidence indicates midazolam maintains a practical edge strictly for rapid onset.

Ahmad M.Alridahie, Saleh K.Almasoud, Ammar K.Alhajjaj et al. · 0 citations
Review Open access Sep 2026

Comparative efficacy of AAC and ibuprofen versus lasmiditan, ubrogepant, and rimegepant for the acute treatment of episodic migraine in adults: a systematic review and network meta-analysis

A range of pharmacologic options is available for acute migraine treatment, yet the efficacy and safety of commonly used over-the-counter (OTC) therapies relative to newer prescription agents remain unclear. Given the scarcity of direct head-to-head trials, this network meta-analysis (NMA) of randomized controlle...

A. Mitra, B. Franks, R. Petruschke et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.